Pfizer: Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials
The registry lists 14 Leukemia, Myelogenous, Chronic, BCR-ABL Positive studies with Pfizer as lead sponsor. 1 are open to participants now and 9 have results posted.
Phase 1 3Phase 2 3Phase 3 2Phase 4 1No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).RecruitingNCT06297161
- Study to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real-life Treatment Outcomes in Hungary: Analysis of National Health Insurance Fund DatabaseCompletedNCT05286528Results posted
- Study of Bosutinib in Japanese Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous LeukemiaCompletedNCT03128411Phase 2Results posted
- A Study To Describe The Real World Use Of Bosutinib In The UK And NetherlandsCompletedNCT02546375Results posted
- Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase InhibitorsTerminatedNCT02228382Phase 4Results posted
- A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous LeukemiaCompletedNCT02130557Phase 3Results posted
- Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008CompletedNCT01903733Not applicableResults posted
- Study Evaluating SKI-606 (Bosutinib) In Japanese Subjects With Philadelphia Chromosome Positive LeukemiasCompletedNCT00811070Phase 2Results posted
- Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CMLCompletedNCT00574873Phase 3Results posted
- Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive LeukemiasCompletedNCT00261846Phase 2Results posted
- Safety And Efficacy Of BosutinibCompletedNCT02501330
- A Drug Interaction Study Between Bosutinib And Aprepitant In Healthy VolunteersCompletedNCT02058277Phase 1
- Bioequivalence And Food Effect Study Of Bosutinib In Healthy SubjectsCompletedNCT01374139Phase 1
- Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy SubjectsCompletedNCT00759837Phase 1